Logo

Celera Licenses Databases to Europe s Largest Biotech Firm

Dec 20, 2001

NEW YORK, Dec. 20 - Celera Genomics has licensed its genomic databases to Serono, Europe's largest biotech firm, Celera said on Thursday.

 

Financial terms of the multi-year subscription agreement were not disclosed.

 

"This agreement is another important element in our expanding genomics program," said Silvano Fumero, senior executive vice president for research and pharmaceutical development at Serono. He added that the Applera unit's mouse and human genome sequences "will support Serono's scientific efforts to discover novel targets and therapeutic proteins."

 

Serono, considered the third-largest biotech in the world in revenue, is based in Geneva.

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.